Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
PR Newswire•27/08/2026•00:30 ET
0
Whiz Insights
Get started
Create a free account to read the full story.